HRH2 and neuropathic pain: It is reported that intracerebroventricular pretreatment with zolantidine (a histamine H2 receptor antagonist), but not mepyramine, abrogated the anti-hypersensitivity effect of central histamine in the spinal nerve ligation (SNL) model of neuropathic pain [27].